GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Ventures Inc (XCNQ:J) » Definitions » Debt-to-EBITDA

Lotus Ventures (XCNQ:J) Debt-to-EBITDA : -1.48 (As of Aug. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Lotus Ventures Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Lotus Ventures's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$2.43 Mil. Lotus Ventures's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$0.00 Mil. Lotus Ventures's annualized EBITDA for the quarter that ended in Aug. 2023 was C$-1.64 Mil. Lotus Ventures's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2023 was -1.48.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Lotus Ventures's Debt-to-EBITDA or its related term are showing as below:

XCNQ:J' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.46   Med: 0.11   Max: 0.32
Current: -2.46

During the past 12 years, the highest Debt-to-EBITDA Ratio of Lotus Ventures was 0.32. The lowest was -2.46. And the median was 0.11.

XCNQ:J's Debt-to-EBITDA is ranked worse than
100% of 659 companies
in the Drug Manufacturers industry
Industry Median: 1.71 vs XCNQ:J: -2.46

Lotus Ventures Debt-to-EBITDA Historical Data

The historical data trend for Lotus Ventures's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Ventures Debt-to-EBITDA Chart

Lotus Ventures Annual Data
Trend Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.10 0.32 0.32 -0.26

Lotus Ventures Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.85 6.51 -4.78 -1.48

Competitive Comparison of Lotus Ventures's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Ventures's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Ventures's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lotus Ventures's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lotus Ventures's Debt-to-EBITDA falls into.



Lotus Ventures Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Lotus Ventures's Debt-to-EBITDA for the fiscal year that ended in Aug. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.011 + 0) / -3.952
=-0.26

Lotus Ventures's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.434 + 0) / -1.644
=-1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Aug. 2023) EBITDA data.


Lotus Ventures  (XCNQ:J) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Lotus Ventures Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lotus Ventures's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotus Ventures (XCNQ:J) Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 1010, Vancouver, BC, CAN, V6E 2Y3
Lotus Ventures Inc is a licensed cannabis producer that serves customers in Canada. The company created a purpose-built facility with proprietary standard operating procedures to reliably produce rare and high-quality strains of cannabis for consumers looking for a consistent experience.
Executives
Gary Kenneth Mathiesen Senior Officer